Bone marrow transplant is a complex procedure with significant risks. My passion is to make it so safe that anyone could have a successful transplant.
Where I see patients (2)
No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma.
Bone marrow transplantation
Intestinal microbiome and metabolome signatures in patients with chronic granulomatous disease.
The Journal of allergy and clinical immunology
Genotype, Oxidase Status, and Preceding Infection or Autoinflammation Do Not Affect Allogeneic HCT Outcomes for CGD.
JSP191 Antibody Targeting Conditioning in SCID Patients
The number of subjects experiencing dose limiting toxicities including adverse events and serious adverse events will be assessed.
Conditioning SCID Infants Diagnosed Early
Humoral immune reconstitution by 2 years post HCT, defined by specific antibody response to tetanus toxoid. Criteria for evaluation of humoral immune response are the following: Donor T cell chimerism ≥50% B cell count ≥50 cells/m...
EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
Patients will be monitored for adverse events related to the infusion of EBV CTLs
Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Ste...
To longitudinally and quantitatively describe the HRQoL of a diverse nation-wide cohort of sibling pediatric Hematopoietic Stem Cell (HSC) donors (Peripheral Blood Stem Cell or Bone Marrow) and to compare their HRQoL to that of (1...
Tender wagging care